급성 골수성 백혈병으로 항암 치료 후 환자에서 발생한 간과 소장 털곰팡이증: 증례보고 및 문헌고찰
Hepatic and Small Bowel Mucormycosis after Chemotherapy in a Patient with Acute Myeloid Leukemia: A Case Report and Literature Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We present a case of a 64-year-old woman with acute myeloid leukemia who developed a hepatic abscess during the neutropenic period after induction chemotherapy. To treat the abscess, meropenem and ciprofloxacin were administered to target Klebsiella pneumoniae and percutaneous drainage performed. As a result, the patient’s fever and c-reactive protein (CRP) subsequently improved. After six weeks of antibiotic therapy, an abdominal computed tomography scan revealed remains of the liver abscess as well as an ileus in the small bowel. Molds from the Mucor genus were cultured from repeated liver abscess drainage and an abscess wall biopsy confirmed hepatic mucormycosis. Along with administration of amphotericin-B deoxycholate for four weeks, we performed lobectomy for hepatic mucormycosis and small bowel resection for a suspected small bowel mucormycosis. After these operations, the patient received liposomal amphotericin B for three weeks and was then maintained with oral posaconazole for more than four weeks. Our case report suggests that hepatic mucormycosis should be considered when a hepatic abscess exhibits a retarded response to antibacterial agents, especially for patients with risk factors. In addition,because an isolated hepatic mucormycosis is infrequent, a thorough search for the extent of the disease is necessary before surgical resection.
Abstract
We present a case of a 64-year-old woman with acute myeloid leukemia who developed a hepatic abscess during the neutropenic period after induction chemotherapy. To treat the abscess, meropenem and ciprofloxacin were administered to target Klebsiella pneumoniae and percutaneous drainage performed. As a result, the patient’s fever and c-reactive protein (CRP) subsequently improved. After six weeks of antibiotic therapy, an abdominal computed tomography scan revealed remains of the liver abscess as well as an ileus in the small bowel. Molds from the Mucor genus were cultured from repeated liver abscess drainage and an abscess wall biopsy confirmed hepatic mucormycosis. Along with administration of amphotericin-B deoxycholate for four weeks, we performed lobectomy for hepatic mucormycosis and small bowel resection for a suspected small bowel mucormycosis. After these operations, the patient received liposomal amphotericin B for three weeks and was then maintained with oral posaconazole for more than four weeks. Our case report suggests that hepatic mucormycosis should be considered when a hepatic abscess exhibits a retarded response to antibacterial agents, especially for patients with risk factors. In addition,because an isolated hepatic mucormycosis is infrequent, a thorough search for the extent of the disease is necessary before surgical resection.
참고문헌 (29)
- Kontoyiannis DP., "How I treat mucormycosis", Blood, 118, pp.1216~1224 (2011)
- Suh IW., "Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia", J Korean Med Sci, 15, pp.351~354 (2000)
- Kume H., "Epidemiology of visceral mycoses in autopsy cases in Japan : comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan", Med Mycol J, 52, pp.117~127 (2011)
- Gleissner B., "Improved outcome of zygomycosis in patients with hematological diseases?", Leuk Lymphoma, 45, pp.1351~1360 (2004)
- Roden MM., "Epidemiology and outcome of zygomycosis : a review of 929 reported cases", Clin Infect Dis, 41, pp.634~653 (2005)
- Su H., "Hepatic mucormycosis with abscess formation", Diagn Microbiol Infect Dis, 73, pp.192~194 (2012)
- Li KW., "Hepatic mucormycosis mimicking hilar cholangiocarcinoma : a case report and literature review", World J Gastroenterol, 16, pp.1039~1042 (2010)
- Lüer S., "Treatment of intestinal and hepatic mucormycosis in an immunocompromized child", Pediatr Blood Cancer, 52, pp.872~874 (2009)
- Mezhir JJ., "Successful nonoperative management of gastrointestinal mucormycosis : novel therapy for invasive disease", Surg Infect(Larchmt), 10, pp.447~451 (2009)
- Greenberg RN., "Posaconazole as salvage therapy for zygomycosis", Antimicrob Agents Chemother, 50, pp.126~133 (2006)
- Mekeel KL., "Hepatic mucormycosis in a renal transplant recipient", Transplantation, 79, pp.1636~ (2005)
- Blin N., "Disseminated Mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin’s lymphoma", Leuk Lymphoma, 45, pp.2161~2163 (2004)
- Tsaousis G., "Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomial amphotericin B", Scand J Infect Dis, 32, pp.335~337 (2000)
- Villani A., "Disseminated mucormycosis. A rare case in pediatric intensive care", Minerva Anestesiol, 63, pp.249~252 (1997)
- Oliver MR., "Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine", Clin Infect Dis, 22, pp.521~524 (1996)
- Al-Asiri RH., "Isolated hepatic mucormycosis in an immunocompetent child", Am J Gastroenterol, 91, pp.606~607 (1996)
- ter Borg F., "Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia", Scand J Infect Dis, 22, pp.499~501 (1990)
- Spellberg B., "Novel perspectives on mucormycosis : pathophysiology, presentation, and management", Clin Microbiol Rev, 18, pp.556~569 (2005)
- Marcus SG., "Hepatic abscess in cancer patients. Characterization and management", Arch Surg, 128, pp.1358~1364 (1993)
- Sun QN., "In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes", Antimicrob Agents Chemother, 46, pp.1581~1582 (2002)
- Chau AS., "Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae", Antimicrob Agents Chemother, 50, pp.3917~3919 (2006)
- Kontoyiannis DP., "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy : a case-control observational study of 27 recent cases", J Infect Dis, 191, pp.1350~1360 (2005)
- Imhof A., "Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole", Clin Infect Dis, 39, pp.743~746 (2004)
- Tedder M., "Pulmonary mucormycosis : results of medical and surgical therapy", Ann Thorac Surg, 57, pp.1044~1050 (1994)
- Ibrahim AS., "Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro", Infect Immun, 73, pp.778~783 (2005)
- Pagano L., "Zygomycosis : Current approaches to management of patients with haematological malignancies", Br J Haematol, 146, pp.597~606 (2009)
- 김우재, "털곰팡이증: Amphotericin B 치료 실패 후 Posaconazole로 호전된 1예", 대한내과학회지, 79(5), pp.587~591 (2010), 대한내과학회
- Perkhofer S., "Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro", Antimicrob Agents Chemother, 52, pp.2636~2638 (2008)
- Greenberg RN., "Posaconazole as salvage therapy for zygomycosis", Antimicrob Agents Chemother, 50, pp.126~133 (2006)